ClinicalTrials.Veeva

Menu

Real-World Registry Study on Patient Satisfaction With TransLoc 3D SI Joint Fusion (RELIEF)

C

CornerLoc

Status

Enrolling

Conditions

Sacroiliac; Fusion
Sacroiliac Joint Dysfunction

Treatments

Device: TransLoc 3D SI Joint Fusion System

Study type

Observational

Funder types

Industry

Identifiers

NCT06487936
RELIEF-02-24

Details and patient eligibility

About

This is a multi-center, consecutive enrollment registry study to evaluate patient satisfaction post SI Fusion with the TransLoc 3D SI Fusion System.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 year or older
  • Confirmed Implant of the Transloc 3D Fusion System
  • Did not have Transloc device removed or another manufacturer device implanted post Transloc
  • Does not have other manufacturer's titanium or metal implant
  • Patient may be included with prior allograft implant
  • Willing to participate and give written consent
  • Must have or planned CT post ≥1 year per standard of care

Exclusion criteria

  • Patient is younger than 18 years
  • Patient is unable to sign the Informed Consent
  • Implant of other manufacturer's titanium or alternative metal implant
  • Revision with another manufacturer's implant
  • Fracture or unresolved trauma of implant side after implantation of TransLoc
  • Patient unwilling to participate in Patient Satisfaction Survey
  • Patient has not returned for Standard of Care follow-up

Trial design

120 participants in 1 patient group

Implanted TransLoc 3D SIJ Fusion Patients
Description:
Patients who were diagnosed with sacroiliitis and were treated with the TransLoc 3D System ≥ 1 year ≤ 18 months at the time of consent.
Treatment:
Device: TransLoc 3D SI Joint Fusion System

Trial contacts and locations

1

Loading...

Central trial contact

Carley Wiegner; Bob Compton

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems